Physician profile
Gregory C Kasper
NPI 1245232602
$10,699.12
in general payments reported to CMS, 2019-2025
32 companies · $4,633 in 2025
The $4,633 reported for 2025 was more than what 83% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $58.20 · 2021: $327 · 2022: $677 · 2023: $1,609 · 2024: $2,821 · 2025: $4,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,194 · Honoraria: $2,000 · Travel and Lodging: $763 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,193.86 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $762.76 |
| Education | $106.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| My01 INC. | $2,338.70 | 2024-2025 | My01 Continuous Compartmental Pressure Monitor |
| Medtronic, INC. | $2,006.32 | 2022-2025 | In.Pact Admiral, Endurant Iis, Concertotm |
| Endologix LLC | $1,994.03 | 2022-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| W. L. Gore & Associates, INC. | $1,436.90 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Penumbra, INC. | $573.62 | 2019-2024 | Indigo System |
| Inari Medical, INC. | $397.32 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $321.35 | 2023-2024 | Venovo, Covera, Lutonix Drug Coated Balloon |
| Silk Road Medical, INC. | $270.84 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $264.91 | 2025 | Esprit |
| Bolton Medical INC | $204.78 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Shockwave Medical, INC | $193.03 | 2021 | |
| Cook Medical LLC | $128.66 | 2024 | Zilver Ptx |
| Medtronic Vascular, INC. | $73.16 | 2019 | |
| Tactile Systems Technology INC | $63.69 | 2020-2025 | Nimbl, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $47.14 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $41.28 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Surmodics, INC. | $35.75 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Solventum Corporation | $30.44 | 2024 | Snap, Activ.A.C. |
| Humacyte Global, INC. | $26.33 | 2025 | Symvess |
| Organogenesis INC. | $26.25 | 2023 | Puraply |
| Reflow Medical INC | $25.53 | 2025 | |
| Mimedx Group, INC. | $24.50 | 2024 | |
| Pfizer INC. | $22.96 | 2022 | |
| Aroa Biosurgery Incorporated | $22.94 | 2024 | |
| Teleflex LLC | $18.82 | 2023 | Manta |
| Philips North America LLC | $18.64 | 2025 | Labosys |
| Cardiovascular Systems INC. | $18.39 | 2023 | |
| Smith+Nephew, INC. | $17.95 | 2024 | Collagenase Santyl |
| Lemaitre Vascular, INC. | $15.04 | 2025 | Hydro Lemaitre Valvulotome |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 2023 | Eliquis |
| Amgen INC. | $13.22 | 2019 | |
| Boston Scientific Corporation | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.